Edition:
United States

Julie Steenhuysen

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

Nov 13 2017

Nanotech, gene editing used to edit cholesterol gene: U.S. study

CHICAGO U.S. researchers have used nanotechnology plus the powerful CRISPR-Cas9 gene editing tool to turn off a key cholesterol-related gene in mouse liver cells, an advance that could lead to new ways to correct genes that cause high cholesterol and other liver diseases.

Oct 31 2017

U.S. experts set research agenda to meet 'Cancer Moonshot' goals

CHICAGO It will take a major shift in the way cancer research is done in the United States to meet the ambitious goals set out by the U.S. Cancer Moonshot, researchers said on Tuesday.

Oct 31 2017

Exclusive: U.S. needs to improve oversight of labs handling dangerous pathogens - report

CHICAGO A year-long audit of the program overseeing U.S. labs that handle lethal pathogens such as Ebola and anthrax found overworked safety inspectors, an absence of independent review and weak biosafety protections that could expose lab workers and the public to harm, a government report will say on Tuesday.

Oct 25 2017

U.S. scientists unveil powerful new tools to fix genetic faults

CHICAGO U.S. scientists on Wednesday unveiled two new molecular editing tools designed to fix mutations that cause the majority of human genetic diseases, some of which have no known treatment.

Oct 19 2017

New H7N9 bird flu strain in China has pandemic potential: study

CHICAGO Lab experiments on a new strain of the H7N9 bird flu circulating in China suggest the virus can transmit easily among animals and can cause lethal disease, raising alarm that the virus has the potential to trigger a global human pandemic, researchers reported on Thursday.

Oct 19 2017

New H7N9 bird flu strain in China has pandemic potential-study

CHICAGO, Oct 19 Lab experiments on a new strain of the H7N9 bird flu circulating in China suggest the virus can transmit easily among animals and can cause lethal disease, raising alarms that the virus has the potential for triggering a global human pandemic, researchers reported on Thursday.

Oct 12 2017

U.S. NIH, 11 drugmakers partner to accelerate cancer therapy research

The Trump Administration threw its support behind a public-private partnership with 11 drug companies to advance a new class of drugs that uses the body's immune system to fight cancer.

Oct 04 2017

Zika vaccine shows promise in early human trial

CHICAGO A DNA-based Zika vaccine from Inovio Pharmaceuticals Inc and South Korea's GeneOne Life Science Inc induced anti-Zika immune responses in an early stage human trial, U.S. researchers reported on Wednesday.

Oct 03 2017

Obesity-related cancers rising, threatening gains in U.S. cancer rates

CHICAGO The rates of 12 obesity-related cancers rose by 7 percent from 2005 to 2014, an increase that is threatening to reverse progress in reducing the rate of cancer in the United States, U.S. health officials said on Tuesday.

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary